Buprenorphine/Naloxone Treatment of Addictions – Home Induction Guide (May 2024)

Buprenorphine/Naloxone Treatment of Addictions – AIM The Next Stage of Buprenorphine Care for OUD (May 2024)

Buprenorphine/Naloxone Treatment of Addictions – Buprenorphine/Naloxone Treatment Agreement and Consent Form (May 2024)

Buprenorphine/Naloxone Treatment of Addictions – COWS Scale (May 2024)

Buprenorphine/Naloxone Treatment of Addictions – DSM-5 Clinical Diagnostic Criteria for Opioid Use Disorder (May 2024)

Buprenorphine/Naloxone Treatment of Addictions – OOWs Tool (May 2024)

Buprenorphine/Naloxone Treatment of Addictions – SOWS (May 2024)

Buprenorphine/Naloxone Treatment of Addictions – Time for Change Form (May 2024)

Buprenorphine/Naloxone Treatment of Addictions -Enhanced Supports – Suboxone Treatment of Addictions (May 2024)

Buprenorphine/Naloxone Treatment of Addictions – Benzodiazepine Mgmt. Withdrawal (May 2024)

Buprenorphine/Naloxone Treatment of Addictions – Buprenorphine & Opiod Use Disorder (May 2024)

Buprenorphine/Naloxone Treatment of Addictions – Buprenorphine-Naloxone Microdosing – Tool for OAT Induction (May 2024)

Buprenorphine/Naloxone Treatment of Addictions – Case Studies (May 2024)

Buprenorphine/Naloxone Treatment of Addictions – Clinical Interpret of DTR (May 2024)

Buprenorphine/Naloxone Treatment of Addictions – CMHA Buprenorphine/Naloxone Microdosing: The Bernese Method (May 2024)

Buprenorphine/Naloxone Treatment of Addictions – Discontinuing Buprenorphine Treatment of OUD: What Do We (Not) Know? (May 2024)

Buprenorphine/Naloxone Treatment of Addictions – Induction Overview (May 2024)

Buprenorphine/Naloxone Treatment of Addictions – Managing OUD in Primary Care – PEER Simplified Guide (May 2024)

Buprenorphine/Naloxone Treatment of Addictions – Personalizing The Treatment of SUD (Volkow) (May 2024)

Buprenorphine/Naloxone Treatment of Addictions – Sublocade Treatment (May 2024)